Finzati - Logo
BMYMP logo

Bristol-Myers Squibb Company PFD CONV 2

BMYMP • Drug Manufacturers - General
$66.82
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$136.85B
Growth
5.1%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 14.6%Positive free cash flow · 6.29Consistent free cash flow · 5/5Reasonable earnings multiple · 15.61High debt level · 2.55
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$66.82
Change0.00%
Shares Out2.05B
Market Cap$136.85B
Enterprise Value$168.90B
52W Range400.00 - 1050.00
Beta0.27
P/E14.74
P/S2.78
P/B6.13
P/FCF11.12
EV/Sales3.43

Investment DNA

How strong this company looks for long-term investors

74
out of 100
Business Quality
Margins, moat, returns
81/100
Financial Strength
Debt, cash, stability
61/100
Growth Potential
Revenue and expansion
36/100
Price Attractiveness
Cheap or expensive today
78/100
Why this score▼
Stable or improving margins · 14.6%Positive free cash flow · 6.29Consistent free cash flow · 5/5Reasonable earnings multiple · 15.61High debt level · 2.55Negative growth trend

Analyst view

Analyst sentiment and price target

BMY
Analyst sentiment
Based on 42 analyst votes · 2026-09-05
71/100
Bullish
Bullish
20
Hold
20
Bearish
2
Price Target
2026-07-31
Low
$40.00
Mean
$63.25
Median
$65.00
High
$75.00

Company Overview

IPO: 12/8/2003
Industry: Drug Manufacturers - General
P/B i: 6.13
Debt / Equity i: 2.55
Operating Margin: 26.34%
Net Margin: 14.63%
ROE i: -
ROIC: -

Financial Health

Score12 / 20
Debt / Equity: 2.55
Current Ratio: 1.26
Quick Ratio: 1.14
Status: Good

Warnings

  • High debt level

Insider Transactions

Recent executive and insider activity

Arduini Peter J
Transaction: 06/30/2026
BUY
Change
—
Price
Not reported
Filing
07/02/2026
Type
BUY
McMullen Michael R.
Transaction: 06/30/2026
BUY
Change
—
Price
Not reported
Filing
07/02/2026
Type
BUY
Rice Derica W
Transaction: 06/30/2026
BUY
Change
—
Price
Not reported
Filing
07/02/2026
Type
BUY